Information technologyWhat's working – and what's not – in the effort to revolutionize patient record-keeping | Business Insider
Each hospital has its own electronic health records system, but connecting those, at the moment is almost impossible. And they're still being described as “clunky” or stuck in the 1990s compared to the flashy consumer technology that we use every day. Those two shortcomings are what healthcare experts hope changes, and soon.
Why a Jacksonville company is making the data it collects available to its customers | Jacksonville (Fla.) Business Journal
As an inventory management tool for the medical device industry, iTraycer collects a lot of data. Now, the creator of iTraycer, Medical Tracking Solutions, is looking to present that data so its customers can learn about their inventory and how it’s being moved.
Medical devices and equipmentSt. Jude says report by short sellers 'false and misleading' | Reuters
Medical device manufacturer St. Jude Medical Inc. said on Friday a report by short-selling firm Muddy Waters and a cyber-security researcher alleging its heart devices were riddled with bugs was “false and misleading.”
PharmaceuticalsGlaxo bets it can shake up HIV treatment | The Wall Street Journal
GlaxoSmithKline PLC is pinning the future of its HIV business on an audacious bet: upending the decades-old treatment strategy that has turned a fatal illness into a chronic condition.
Mylan Pharmaceuticals has spent millions this year on television ads and celebrity testimonials that implicitly promote the EpiPen – without ever mentioning its name. Welcome to the world of unbranded ads, a stealthy and lightly regulated form of drug marketing focused on educating the public about a health condition, which the pharma company just happens to sell a product to treat.
The top law enforcement official in New Hampshire, a state ravaged by the opioid epidemic, accused the manufacturer of OxyContin on Friday of stonewalling demands for information the company collects about suspected criminal trafficking of its painkiller.
PhysiciansTo help cancer patients, lawmakers pushed access to a controversial doctor | Stat
The call to Congressman Ted Yoho’s office was a matter of life and death: A constituent was seeking help for a 5-year-old great-nephew who was suffering from a terrible brain tumor. Could the Florida Republican push the Food and Drug Administration to give the boy access to an unapproved drug treatment that the caller had heard would help?